Human cytidine deaminase: A biochemical characterization of its naturally occurring variants

Add time:07/30/2019    Source:sciencedirect.com

Human cytidine deaminase is an enzyme of the pyrimidine salvage pathways that metabolizes several cytosine nucleoside analogs used as prodrugs in chemotherapy. We carried out a characterization of the cytidine deaminase 79A>C and 208G>A Single Nucleotide Polymorphisms, in order to highlight their functional role and provide data that could help fine-tune the chemotherapic use of cytosine nucleosides in patients carrying the above mentioned SNPs. The 79A>C SNP results in a K27Q change in a protein region not involved in the catalytic event. The 208G>A SNP produces an alanine to threonine substitution (A70T) within the conserved catalytic domain. Q27 variant is endowed with a greater catalytic efficiency toward the natural substrates and the antileukemic agent cytarabine (Ara-C), when compared to K27 variant. Molecular modeling, protein stability experiments and site-directed mutagenesis suggest that K27 variant may have an increased stability with respect to Q27 due to an ionic interaction between a lysine residue at position 27 and a glutamate residue at position 24. The T70 variant has a lower catalytic efficiency toward the analyzed substrates when compared to the A70 variant, suggesting that patients carrying the 208G>A SNP may have a greater exposure to cytosine based pro drugs, with possible toxicity consequences.

We also recommend Trading Suppliers and Manufacturers of Cytidine 5'-(hydrogen sulfate) (cas 13435-43-3). Pls Click Website Link as below: cas 13435-43-3 suppliers

Prev:Adsorption stages and interfacial orientations of cytidine sulphate at the mercury/electrolyte interface
Next:Role of tyrosine 33 residue for the stabilization of the tetrameric structure of human cytidine deaminase)